The global Biologics Drug Discovery and Development market size is predicted to grow from US$ 1091 million in 2025 to US$ 1996 million in 2031; it is expected to grow at a CAGR of 10.6% from 2025 to 2031.

Biologic drugs have transformed modern medicine and their continued evolution gives greater promise for many patients with serious or untreatable conditions, such as cancer, and existing and emerging infectious diseases, such as COVID-19.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs.

For biologics is expected to be 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022.

The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.

However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.

Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features

• Insight Report provides a comprehensive analysis of the global Biologics Drug Discovery and Development landscape
• Highlights key trends related to product segmentation, company formation, revenue, and market share
• Breaks down the forecast by Type, by Application, geography, and market size

Segmentation by Type

• Vaccines
• Blood and Blood Components
• Cells
• Tissues
• Gene Therapy
• Recombinant Proteins
• Others

Segmentation by Application

• Pharmaceutical and Biotechnology Companies
• Research Laboratories

Market by Region

• Americas
• APAC
• Europe
• Middle East & Africa

Company Coverage

• Thermo Fisher
• Promega
• Beckman
• Sartorius
• Schrodinger
• Absci
• Bio-Rad
• ChemPartner
• STC Biologics
• Biocon Biologics
• Evotec
• Alloy Therapeutics
• Twist Bioscience
• Abzena
• WuXi Biologics
• Frontage Labs
• Bio-Thera Solutions

Key Questions Addressed in this Report